Myelodysplastic Syndromes

Latest News

Myeloid malignancy concept, blood cells floating | image credit: Eleni - stock.adobe.com
Phase 1b/2 Study Supports Use of Telaglenastat and Azacytidine in Advanced MDS

October 18th 2024

A recent study evaluates the dosing, safety, and efficacy of telaglenastat and azacytidine to treat advanced myelodysplastic syndromes (MDS), with promising results.

Cancer cells | Image credit: Sodapeaw - stock.adobe.com
In Lower-Risk MDS, Genomic Dynamics Heighten Likelihood of Treatment

October 11th 2024

Doctor consulting with patient | Image credit: ARMMY PICCA - stock.adobe.com
JAK Inhibitors Show Promise in Concurrent Myeloid Disorders, IADs

October 4th 2024

Hemoglobin is responsible for transporting oxygen throughout the body, which is imperative for a multitude of functions | image credit: Justlight - stock.adobe.com
Low Hemoglobin, IDH2 Mutation Indicative of Poor Survival in MDS

September 21st 2024

Celiac disease and the body | Image Credit: reineg-stock.adobe.com
Celiac Disease Associated With Varying Risks for Cancers

September 13th 2024

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo